---
title: "\uFEFFEthical Considerations of Including Minors in Clinical Trials Using
  the Example of the Indicated Prevention of Psychotic Disorders\uFEFF"
date: '2024-05-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38809160/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240529181135&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Ethical Considerations of Including Minors in Clinical Trials Using
  the Example of the Indicated Prevention of Psychotic Disorders Abstract: As a vulnerable
  group, minors require special protection in studies. For this reason, researchers
  are often reluctant to initiate studies, and ethics committees are reluctant to
  authorize such studies. This often excludes minors from participating in clinical
  studies. This exclusion can lead to researchers and clinicians receiving only incomplete
  data ...'
disable_comments: true
---
Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders Abstract: As a vulnerable group, minors require special protection in studies. For this reason, researchers are often reluctant to initiate studies, and ethics committees are reluctant to authorize such studies. This often excludes minors from participating in clinical studies. This exclusion can lead to researchers and clinicians receiving only incomplete data ...